Since C5ar1 deficiency ameliorated the course of experimental N. meningitidis sepsis (Fig. 3) and its blockade also lowered the proinflammatory cytokine/chemokine levels in a human whole-blood infection model (Fig. 6), we speculated that C5aR1 might therefore represent a potential target for treatment. The gene discussed is C5AR1; the disease is infection.